A detailed history of M&T Bank Corp transactions in Abbott Laboratories stock. As of the latest transaction made, M&T Bank Corp holds 968,493 shares of ABT stock, worth $109 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
968,493
Previous 69,074 1302.11%
Holding current value
$109 Million
Previous $7.88 Million 1302.12%
% of portfolio
0.37%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 19, 2024

BUY
$100.07 - $118.13 $90 Million - $106 Million
899,419 Added 1302.11%
968,493 $110 Million
Q3 2024

Nov 15, 2024

SELL
$100.07 - $118.13 $96.5 Million - $114 Million
-964,431 Reduced 93.32%
69,074 $7.88 Million
Q2 2024

Jul 31, 2024

BUY
$100.73 - $112.44 $3.99 Million - $4.46 Million
39,643 Added 3.99%
1,033,505 $107 Million
Q1 2024

May 07, 2024

SELL
$109.52 - $120.96 $16.3 Million - $18 Million
-148,932 Reduced 13.03%
993,862 $113 Million
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $29.4 Million - $36 Million
325,715 Added 39.86%
1,142,794 $126 Million
Q3 2023

Nov 02, 2023

SELL
$95.53 - $114.62 $6.2 Million - $7.43 Million
-64,866 Reduced 7.35%
817,079 $79.1 Million
Q2 2023

Aug 09, 2023

SELL
$100.78 - $112.29 $980,690 - $1.09 Million
-9,731 Reduced 1.09%
881,945 $96.1 Million
Q1 2023

May 11, 2023

SELL
$96.86 - $114.01 $3.41 Million - $4.02 Million
-35,238 Reduced 3.8%
891,676 $90.3 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $17,015 - $19,962
179 Added 0.02%
926,914 $102 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $3.48 Million - $4.08 Million
36,612 Added 4.11%
926,735 $102 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $1.01 Million - $1.16 Million
-10,390 Reduced 1.15%
890,123 $86.1 Million
Q2 2022

Aug 05, 2022

BUY
$102.07 - $123.37 $12.2 Million - $14.7 Million
119,311 Added 15.27%
900,513 $84.6 Million
Q1 2022

May 09, 2022

BUY
$114.02 - $139.04 $181,291 - $221,073
1,590 Added 0.2%
781,202 $92.5 Million
Q4 2021

Feb 07, 2022

BUY
$115.53 - $141.46 $1.14 Million - $1.4 Million
9,884 Added 1.28%
779,612 $110 Million
Q3 2021

Oct 28, 2021

BUY
$116.66 - $129.06 $3.84 Million - $4.25 Million
32,907 Added 4.47%
769,728 $90.9 Million
Q2 2021

Aug 13, 2021

SELL
$105.79 - $124.53 $3.69 Million - $4.35 Million
-34,921 Reduced 4.52%
736,821 $85.4 Million
Q1 2021

May 06, 2021

BUY
$108.84 - $128.23 $235,638 - $277,617
2,165 Added 0.28%
771,742 $92.5 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $2.06 Million - $2.24 Million
-19,573 Reduced 2.48%
769,577 $84.3 Million
Q3 2020

Nov 06, 2020

BUY
$91.64 - $111.29 $1.1 Million - $1.34 Million
12,045 Added 1.55%
789,150 $85.9 Million
Q2 2020

Jul 29, 2020

SELL
$76.57 - $98.0 $899,927 - $1.15 Million
-11,753 Reduced 1.49%
777,105 $71.1 Million
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $597,732 - $874,047
-9,515 Reduced 1.19%
788,858 $62.3 Million
Q4 2019

Feb 07, 2020

SELL
$78.51 - $87.4 $323,461 - $360,088
-4,120 Reduced 0.51%
798,373 $69.3 Million
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $392,504 - $425,597
4,796 Added 0.6%
802,493 $67.1 Million
Q2 2019

Aug 12, 2019

SELL
$72.88 - $85.0 $225,126 - $262,565
-3,089 Reduced 0.39%
797,697 $67.1 Million
Q1 2019

May 15, 2019

SELL
$66.22 - $80.06 $370,103 - $447,455
-5,589 Reduced 0.69%
800,786 $64 Million
Q4 2018

Feb 01, 2019

SELL
$65.56 - $74.27 $730,994 - $828,110
-11,150 Reduced 1.36%
806,375 $58.3 Million
Q3 2018

Nov 09, 2018

BUY
$60.81 - $73.36 $742,672 - $895,945
12,213 Added 1.52%
817,525 $60 Million
Q2 2018

Aug 10, 2018

BUY
$57.57 - $63.54 $619,741 - $684,008
10,765 Added 1.35%
805,312 $49.1 Million
Q1 2018

May 04, 2018

SELL
$56.27 - $63.62 $1.98 Million - $2.24 Million
-35,178 Reduced 4.24%
794,547 $47.6 Million
Q4 2017

Feb 06, 2018

SELL
$53.68 - $57.47 $715,930 - $766,477
-13,337 Reduced 1.58%
829,725 $47.4 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $18,743 - $20,919
390 Added 0.05%
843,062 $45 Million
Q2 2017

Aug 11, 2017

BUY
N/A
842,672
842,672 $41 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.